Prevalence of Psychological Disorders After Immediate Postpartum Hemorrhage

NCT03120208 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1968

Last updated 2018-12-31

No results posted yet for this study

Summary

The objective of this cross-sectional study is to assess the prevalence of depression at 2 months, 6 months, and 1 year postpartum in women who had an immediate postpartum hemorrhage (immediate PPH defined as blood loss ≥ 500 mL within 24 hours of delivery). The potential serious consequences of PPH may lead to a greater number of psychological disorders in these women than in women without PPH.

Conditions

Interventions

BEHAVIORAL

• The Edinburgh postnatal depression scale (EPDS), validated in French, with a discrimination threshold ≥ 11.

The Edinburgh postnatal depression scale (EPDS), validated in French, with a discrimination threshold ≥ 11.

BEHAVIORAL

The GAD-7 with a discrimination threshold ≥10.

The GAD-7 with a discrimination threshold ≥10.

BEHAVIORAL

• Spielberger's State-Trait anxiety inventory, Form Y (validated in French), with a STAI (form Y-A) discrimination threshold ≥ 46

Spielberger's State-Trait anxiety inventory, Form Y (validated in French), with a STAI (form Y-A) discrimination threshold ≥ 46

BEHAVIORAL

The IES-R, validated in French, with a discrimination threshold ≥ 30.

The IES-R, validated in French, with a discrimination threshold ≥ 30.

BEHAVIORAL

EPDS, MINI, STAI-A and B, IES-R and QEVA (experience)

For the partners

Sponsors & Collaborators

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Marine PRANAL JULIEN · University Hospital, Clermont-Ferrand

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-27
Primary Completion
2019-08-31
Completion
2020-02-29

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03120208 on ClinicalTrials.gov